<?xml version="1.0" encoding="UTF-8"?>
<p>ACE inhibitors block ACE and ARB block the action of angiotensin II on ATI receptors. Both lead to an increased ACE2 activity.
 <sup>
  <xref rid="bibr42-0004563220928361" ref-type="bibr">42</xref>
 </sup> The drugs may alleviate inflammation, decrease endothelial dysfunction and increase insulin sensitivity.
 <sup>
  <xref rid="bibr29-0004563220928361" ref-type="bibr">29</xref>
 </sup> The ARBs have more potential to block the RAS than ACEI, as about 40% of angiotensin II is formed via non-ACE pathways in humans.
 <sup>
  <xref rid="bibr29-0004563220928361" ref-type="bibr">29</xref>
 </sup> ARBs are known to have less side-effects than ACE inhibitors.
</p>
